NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
0.00 (0.00%)
At close: Aug 15, 2025, 12:15 PM

NeuroOne Medical Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-12.32M -11.86M -10M -9.95M
Depreciation & Amortization
246.79K 199.27K 118.62K 80.75K
Stock-Based Compensation
1.34M 1.11M 947.21K 1.79M
Other Working Capital
n/a -1.19M 1.29M -15.8K
Other Non-Cash Items
669.61K 96.4K 212.16K 69.44K
Deferred Income Tax
n/a n/a -11.47K -85.31K
Change in Working Capital
-954.61K -2.43M 1.21M -512.73K
Operating Cash Flow
-11.01M -12.89M -7.52M -8.6M
Capital Expenditures
-120.2K -384.12K -275.23K -67.08K
Cash Acquisitions
n/a n/a 2.97M n/a
Purchase of Investments
n/a -1.47M -3.47M n/a
Sales Maturities Of Investments
n/a 4.5M 500K n/a
Other Investing Acitivies
n/a 7.5K -2.97M n/a
Investing Cash Flow
-120.2K 2.65M -3.24M -67.08K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -119.42K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.48M -1.07M -1.33M 2.71M
Financial Cash Flow
7.27M 7.4M 12.02M 11.53M
Net Cash Flow
-3.86M -2.84M 1.26M 2.86M
Free Cash Flow
-11.13M -13.27M -7.79M -8.67M